Literature DB >> 25774443

Pathological postpartum breast engorgement: prediction, prevention, and resolution.

Nikolay P Alekseev1, Ilyin I Vladimir, Talalaeva E Nadezhda.   

Abstract

BACKGROUND: Severe breast engorgement can cause substantial discomfort for mothers and interfere with an infant's ability to feed at the breast. This study explored the possibility of prediction of pathological postpartum breast engorgement in lactating women in relation to intense breast engorgement at the end of the luteal phase of the menstrual cycle and the possibility of prevention and resolution of postpartum breast engorgement with expression with a breast pump of colostrum before the appearance of transitional milk. SUBJECTS AND METHODS: The first group included 70 women with pathological postpartum breast engorgement. The second group included 52 postpartum women, with 24 women having colostrum extracted by the breast pump from each breast once or twice for a duration of 20-25 minutes sequentially in the first 2-3 days after delivery in addition to the removal of colostrum by the baby, before engorgement developed. Twenty-eight women had colostrum removed only by the baby. The degree of breast engorgement was assessed using the previously published Robson four-level scale.
RESULTS: Of the 70 patients with severe postpartum engorgement studied in the first group, 90% showed intense breast engorgement in the late luteal phase of the menstrual cycle. Expression of colostrum milk in the first experimental group from each breast eliminated excessive breast engorgement in breastfeeding mothers.
CONCLUSIONS: Presence of intense breast engorgement at the end of the luteal phase of the menstrual cycle may be one of the most important indicators useful for predicting severe postpartum breast engorgement. Extraction of colostrum before the appearance of transitional milk lowers the risk of excessive engorgement in breastfeeding women.

Entities:  

Mesh:

Year:  2015        PMID: 25774443      PMCID: PMC4410447          DOI: 10.1089/bfm.2014.0047

Source DB:  PubMed          Journal:  Breastfeed Med        ISSN: 1556-8253            Impact factor:   1.817


  18 in total

1.  Development of sucking behavior in infants with Down's syndrome.

Authors:  K Mizuno; A Ueda
Journal:  Acta Paediatr       Date:  2001-12       Impact factor: 2.299

2.  Proteoglycan-collagen associations in the non-lactating human breast connective tissue during the menstrual cycle.

Authors:  Mechthild Stoeckelhuber; Peter Stumpf; Eugen A Hoefter; Ulrich Welsch
Journal:  Histochem Cell Biol       Date:  2002-07-13       Impact factor: 4.304

3.  Cyclic changes in composition and volume of the breast during the menstrual cycle, measured by magnetic resonance imaging.

Authors:  P A Fowler; C E Casey; G G Cameron; M A Foster; C H Knight
Journal:  Br J Obstet Gynaecol       Date:  1990-07

4.  Circulating immunoreactive oxytocin during the human menstrual cycle comes from the pituitary and is estradiol dependent.

Authors:  L Shukovski; D L Healy; J K Findlay
Journal:  J Clin Endocrinol Metab       Date:  1989-02       Impact factor: 5.958

5.  Serum prolactin concentrations throughout the menstrual cycle of normal women and patients with recent breast cancer.

Authors:  E N Cole; P C England; R A Sellwood; K Griffiths
Journal:  Eur J Cancer       Date:  1977-07       Impact factor: 9.162

6.  Plasma oxytocin concentrations during the menstrual cycle.

Authors:  M D Mitchell; P J Haynes; A B Anderson; A C Turnbull
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1981-09       Impact factor: 2.435

7.  Elevation of oxytocin and the oxytocin-associated neurophysin in the plasma of normal women during midcycle.

Authors:  J A Amico; S M Seif; A G Robinson
Journal:  J Clin Endocrinol Metab       Date:  1981-12       Impact factor: 5.958

Review 8.  Evaluation and management of breast pain.

Authors:  Robin L Smith; Sandhya Pruthi; Lorraine A Fitzpatrick
Journal:  Mayo Clin Proc       Date:  2004-03       Impact factor: 7.616

9.  Distribution and origin of peptide-containing nerve fibres in the rat and human mammary gland.

Authors:  M Eriksson; B Lindh; K Uvnäs-Moberg; T Hökfelt
Journal:  Neuroscience       Date:  1996-01       Impact factor: 3.590

10.  [Blood serum content of prolactin, follicle-stimulating hormone, luteinizing hormone, estradiol and progesterone in women with normal menstrual cycle].

Authors:  U R Khamad'ianov; I P Laricheva; L K Smirnova
Journal:  Probl Endokrinol (Mosk)       Date:  1980 Mar-Apr
View more
  1 in total

1.  ABM Clinical Protocol #20: Engorgement, Revised 2016.

Authors:  Pamela Berens; Wendy Brodribb
Journal:  Breastfeed Med       Date:  2016-04-12       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.